UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 13 | Issue 3 | March 2026

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 11 Issue 12
December-2024
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2412068


Registration ID:
551914

Page Number

a752-a770

Share This Article


Jetir RMS

Title

Quality by design key aspects

Abstract

Quality by design is an essential part of the modern advance to pharmaceutical quality. Every regulatory agency that oversees pharmaceutical products has placed a high priority on quality. Quality means Customer satisfaction with regard to services, goods, and procedures is a measure of quality. The goal of pharmaceutical development is to create high-quality products and manufacturing processes that reliably produce the desired results. It also compares the quality of the product by Quality by design with the quality of the product by end product testing. The ICH Guidelines, specifically Q8 for pharmaceutical development, Q9 for quality risk management, and Q10 for pharmaceutical quality systems, serve as the cornerstone of Quality by Design. The best way to improve the quality of any pharmaceutical product is through QBD. During the product's design and development, it's critical to determine the desired product performance report which includes the critical quality attributes (CQA), the target product profile (TPP), and the quality target product profile (QTPP). QBD can offer valuable insights into the design, development, and production of superior pharmaceutical goods. The historical context, regulatory requirements, and fundamental considerations of the QBD approach are covered in this paper. This article provides an overview of Pharmaceutical Quality by Design (QBD) and explains how it can be used to guarantee the caliber of pharmaceutical analysis. A thorough explanation of the QBD components—method intent, experiment design, and risk assessment is provided.

Key Words

Quality by design(QBD), Process Analytical Technology(PAT), Quality target product profile, Critical quality attributes.

Cite This Article

"Quality by design key aspects", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 12, page no.a752-a770, December-2024, Available :http://www.jetir.org/papers/JETIR2412068.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Quality by design key aspects", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 12, page no. ppa752-a770, December-2024, Available at : http://www.jetir.org/papers/JETIR2412068.pdf

Publication Details

Published Paper ID: JETIR2412068
Registration ID: 551914
Published In: Volume 11 | Issue 12 | Year December-2024
DOI (Digital Object Identifier):
Page No: a752-a770
Country: kurnool, andhra pradesh, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000137

Print This Page

Current Call For Paper

Jetir RMS